Original PeptideStat dataset · updated 2026-08-02
2026 peptide vendortransparency report.
A reproducible view of source quality and documentation coverage across PeptideStat's current marketplace. This report measures what is publicly linked; it does not score product efficacy, sterility or suitability for human use.
Download listing data (CSV)Vendors
6
Listings
23
Markets
2
Direct sources
13
Exact batches
16
Named labs
5
Vendor-level coverage
Documentation, not a star score.
| Vendor | Listings | Direct price sources | Batch-linked listings | Batch records |
|---|---|---|---|---|
| Ascension PeptidesUnited States | 5 | 5 (100%) | 5 (100%) | 10 |
| Ion PeptideUnited States | 4 | 1 (25%) | 0 (0%) | 0 |
| EZ PeptidesUnited States | 3 | 0 (0%) | 0 (0%) | 0 |
| Glacier AminosUnited States | 4 | 1 (25%) | 1 (25%) | 1 |
| Nura PeptideUnited States | 2 | 1 (50%) | 0 (0%) | 0 |
| NOVA LabsUnited Arab Emirates & GCC | 5 | 5 (100%) | 5 (100%) | 5 |
Reuse and citation
Cite the date and the limitation.
Suggested citation: PeptideStat, “2026 Peptide Vendor Transparency Report,” updated 2026-08-02. When using the data, retain the checked date and distinguish vendor-linked documentation from independent product verification.